Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10% Owner | 8 | $301.3K | $0 | 2026-01-02 |
| Herskowitz Neil | Director | 26 | $321.8K | $46 | 2024-12-02 |
| KRANZLER JAY D | Director | 10 | $1.2K | $137 | 2024-11-05 |
| ROSENWALD LINDSAY A MD | Director | 15 | $543.7K | $0 | 2024-09-23 |
| MacLean Alexandra | Chief Executive Officer | 2 | $0 | $0 | 2024-09-23 |
| Jin David | Interim PFO and COO | 2 | $0 | $0 | 2024-09-23 |
| Charles Faith L. | Director | 2 | $0 | $0 | 2024-09-23 |
| Oltmans Curtis Gale | Director | 3 | $0 | $0 | 2024-09-23 |
| Davidow Robert L | 10% Owner | 6 | $0 | $86.6K | 2023-12-11 |
| InvaGen Pharmaceuticals, Inc. | 10% Owner | 1 | $0 | $3.00M | 2022-10-11 |
| Vazzano Joseph Walter | VP Finance & Corp. Controller | 13 | $37.9K | $84.4K | 2021-12-17 |
| Lu Lucy | President, CEO | 6 | $0 | $0 | 2021-12-17 |
| Ingram Elizabeth Garrett | Director | 1 | $100.3K | $0 | 2019-09-12 |
| Paley Jeffrey | Director | 3 | $78.6K | $0 | 2018-12-10 |
| Reines Scott | Interim Chief Medical Officer | 1 | $0 | $0 | 2018-08-07 |
| SAMAD AKHTAR | Director | 1 | $0 | $0 | 2018-08-07 |
| WEISS MICHAEL S | Director | 1 | $0 | $0 | 2018-08-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10% Owner | A Award | 2026-01-02 | 2026-01-06 | 111,209 | — | $0 | 439,733 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2025-03-31 | 2025-04-02 | 33,724 | — | $0 | 328,524 | SEC↗ |
| Herskowitz Neil | Director | S Sale | 2024-12-02 | 2024-12-03 | 23 | $2.00 | $46 | 97 | SEC↗ |
| KRANZLER JAY D | Director | S Sale | 2024-11-05 | 2024-11-07 | 61 | $2.24 | $137 | 559 | SEC↗ |
| KRANZLER JAY D | Director | P Buy | 2024-09-30 | 2024-10-01 | 497 | $2.50 | $1.2K | 620 | SEC↗ |
| KRANZLER JAY D | Director | P Buy | 2024-09-27 | 2024-10-01 | 3 | $2.40 | $7 | 123 | SEC↗ |
| Charles Faith L. | Director | A Award deriv | 2024-09-23 | 2024-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KRANZLER JAY D | Director | A Award deriv | 2024-09-23 | 2024-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Oltmans Curtis Gale | Director | A Award deriv | 2024-09-23 | 2024-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Herskowitz Neil | Director | A Award deriv | 2024-09-23 | 2024-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award deriv | 2024-09-23 | 2024-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Jin David | Interim PFO and COO | A Award | 2024-09-23 | 2024-09-25 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MacLean Alexandra | Chief Executive Officer | A Award | 2024-09-23 | 2024-09-25 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2024-04-16 | 2024-04-17 | 413,507 | — | $0 | 3,547,393 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2024-01-02 | 2024-01-03 | 2,101,496 | — | $0 | 3,133,886 | SEC↗ |
| Davidow Robert L | 10% Owner | S Sale | 2023-12-11 | 2023-12-13 | 264,000 | $0.14 | $37.0K | 681,000 | SEC↗ |
| Davidow Robert L | 10% Owner | S Sale | 2023-12-11 | 2023-12-13 | 20,000 | $0.14 | $2.8K | 80,000 | SEC↗ |
| Davidow Robert L | 10% Owner | S Sale | 2023-12-11 | 2023-12-13 | 18,000 | $0.15 | $2.7K | 22,000 | SEC↗ |
| Davidow Robert L | 10% Owner | S Sale | 2023-12-11 | 2023-12-13 | 61,000 | $0.14 | $8.5K | 74,000 | SEC↗ |
| Davidow Robert L | 10% Owner | S Sale | 2023-12-11 | 2023-12-13 | 126,000 | $0.14 | $17.6K | 215,800 | SEC↗ |
| Davidow Robert L | 10% Owner | S Sale | 2023-12-11 | 2023-12-13 | 128,000 | $0.14 | $17.9K | 147,000 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | P Buy | 2023-09-08 | 2023-09-12 | 418,410 | $0.72 | $301.3K | 1,032,390 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2023-09-08 | 2023-09-12 | 348,675 | $0.72 | $251.0K | 354,318 | SEC↗ |
| Herskowitz Neil | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Oltmans Curtis Gale | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KRANZLER JAY D | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Jin David | Interim PFO and COO | A Award deriv | 2023-06-30 | 2023-07-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Charles Faith L. | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MacLean Alexandra | Chief Executive Officer | A Award deriv | 2023-06-29 | 2023-07-03 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-03-31 | 2023-04-04 | 52,419 | — | $0 | 613,980 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2023-01-03 | 2023-01-04 | 231,316 | — | $0 | 561,561 | SEC↗ |
| Fortress Biotech, Inc. | 10% Owner | A Award | 2022-12-31 | 2023-01-04 | 90,909 | — | $0 | 330,245 | SEC↗ |
| InvaGen Pharmaceuticals, Inc. | 10% Owner | S Sale | 2022-10-11 | 2022-10-13 | 388,888 | $7.71 | $3.00M | 0 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | A Award | 2021-12-17 | 2021-12-20 | 100,505 | — | $0 | 165,757 | SEC↗ |
| Lu Lucy | President, CEO | A Award | 2021-12-17 | 2021-12-20 | 411,616 | — | $0 | 748,949 | SEC↗ |
| Oltmans Curtis Gale | Director | A Award | 2021-12-17 | 2021-12-21 | 49,020 | — | $0 | 49,020 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2021-12-17 | 2021-12-21 | 20,000 | — | $0 | 183,744 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2021-12-17 | 2021-12-21 | 49,020 | — | $0 | 163,744 | SEC↗ |
| KRANZLER JAY D | Director | A Award | 2021-12-17 | 2021-12-21 | 49,020 | — | $0 | 113,683 | SEC↗ |
| KRANZLER JAY D | Director | A Award | 2021-12-17 | 2021-12-21 | 20,000 | — | $0 | 133,683 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | S Sale | 2021-09-15 | 2021-09-15 | 7,160 | $1.62 | $11.6K | 65,252 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2021-05-06 | 2021-05-07 | 2,500 | $3.99 | $10.0K | 134,724 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | S Sale | 2020-08-20 | 2020-08-21 | 3,840 | $12.13 | $46.6K | 57,412 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2020-06-16 | 2020-06-16 | 10,000 | — | $0 | 132,224 | SEC↗ |
| KRANZLER JAY D | Director | A Award | 2020-06-16 | 2020-06-16 | 10,000 | — | $0 | 84,663 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | P Buy | 2020-03-10 | 2020-03-10 | 1,889 | $7.94 | $15.0K | 61,252 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | P Buy | 2020-03-09 | 2020-03-10 | 1,400 | $7.99 | $11.2K | 59,263 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | P Buy | 2020-03-09 | 2020-03-10 | 100 | $7.97 | $797 | 59,363 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2020-02-27 | 2020-03-02 | 2,400 | $8.20 | $19.7K | 122,224 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2020-02-26 | 2020-03-02 | 161 | $8.73 | $1.4K | 119,824 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2020-02-25 | 2020-02-25 | 10,000 | $9.31 | $93.1K | 119,663 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | P Buy | 2020-02-25 | 2020-02-25 | 1,200 | $9.09 | $10.9K | 57,863 | SEC↗ |
| Lu Lucy | President, CEO | A Award deriv | 2020-02-12 | 2020-02-13 | 110,959 | — | $0 | 246,576 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | A Award deriv | 2020-02-12 | 2020-02-13 | 22,727 | — | $0 | 50,505 | SEC↗ |
| Ingram Elizabeth Garrett | Director | P Buy | 2019-09-12 | 2019-09-16 | 16,000 | $6.27 | $100.3K | 16,000 | SEC↗ |
| Herskowitz Neil | Director | A Award | 2019-08-27 | 2019-08-28 | 10,000 | — | $0 | 109,663 | SEC↗ |
| KRANZLER JAY D | Director | A Award | 2019-08-27 | 2019-08-28 | 10,000 | — | $0 | 74,663 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | S Sale | 2019-08-09 | 2019-08-12 | 2,375 | $5.56 | $13.2K | 56,663 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | S Sale | 2019-08-08 | 2019-08-12 | 2,313 | $5.62 | $13.0K | 59,038 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-06-18 | 2019-06-19 | 2,000 | $5.83 | $11.7K | 99,663 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-06-17 | 2019-06-19 | 3,000 | $5.88 | $17.6K | 97,663 | SEC↗ |
| Lu Lucy | President, CEO | A Award deriv | 2019-06-03 | 2019-06-05 | 135,617 | — | $0 | 135,617 | SEC↗ |
| Vazzano Joseph Walter | Chief Financial Officer | A Award deriv | 2019-06-03 | 2019-06-05 | 27,778 | — | $0 | 27,778 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-04-15 | 2019-04-15 | 1,000 | $4.52 | $4.5K | 94,663 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-03-29 | 2019-03-29 | 1,400 | $5.11 | $7.2K | 93,663 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-03-28 | 2019-03-29 | 600 | $5.11 | $3.1K | 92,263 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-02-25 | 2019-02-25 | 5,000 | $5.46 | $27.3K | 91,663 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-02-05 | 2019-02-06 | 1,850 | $5.77 | $10.7K | 86,663 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-02-04 | 2019-02-06 | 7,000 | $5.91 | $41.4K | 84,813 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-01-30 | 2019-02-01 | 650 | $5.91 | $3.8K | 77,813 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-01-29 | 2019-01-30 | 8,553 | $5.91 | $50.5K | 77,163 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2019-01-28 | 2019-01-30 | 1,447 | $5.84 | $8.5K | 68,610 | SEC↗ |
| Paley Jeffrey | Director | P Buy | 2018-12-10 | 2018-12-12 | 5,000 | $4.76 | $23.8K | 79,663 | SEC↗ |
| Paley Jeffrey | Director | P Buy | 2018-12-03 | 2018-12-12 | 10,000 | $5.48 | $54.8K | 74,663 | SEC↗ |
| SAMAD AKHTAR | Director | G Gift | 2018-08-07 | 2018-08-08 | 14,663 | — | $0 | 64,663 | SEC↗ |
| Paley Jeffrey | Director | G Gift | 2018-08-07 | 2018-08-08 | 14,663 | — | $0 | 64,663 | SEC↗ |
| WEISS MICHAEL S | Director | G Gift | 2018-08-07 | 2018-08-08 | 14,663 | — | $0 | 24,663 | SEC↗ |
| Reines Scott | Interim Chief Medical Office | G Gift | 2018-08-07 | 2018-08-08 | 10,000 | — | $0 | 45,000 | SEC↗ |
| KRANZLER JAY D | Director | G Gift | 2018-08-07 | 2018-08-08 | 14,663 | — | $0 | 64,663 | SEC↗ |
| Herskowitz Neil | Director | G Gift | 2018-08-07 | 2018-08-08 | 14,663 | — | $0 | 67,163 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | G Gift | 2018-08-07 | 2018-08-08 | 14,663 | — | $0 | 84,663 | SEC↗ |
| Lu Lucy | President, CEO | G Gift | 2018-08-07 | 2018-08-08 | 250,000 | — | $0 | 807,333 | SEC↗ |
| Vazzano Joseph Walter | VP Finance & Corp. Controlle | G Gift | 2018-08-07 | 2018-08-08 | 30,000 | — | $0 | 61,351 | SEC↗ |
| Vazzano Joseph Walter | VP Finance & Corp. Controlle | A Award | 2018-06-28 | 2018-06-28 | 1,351 | $3.66 | $4.9K | 31,351 | SEC↗ |
| Lu Lucy | President, CEO | A Award | 2018-06-14 | 2018-06-15 | 5,000 | $4.00 | $20.0K | 557,333 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-08 | 2018-06-11 | 5,234 | $4.34 | $22.7K | 25,234 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-08 | 2018-06-12 | 5,234 | $4.34 | $22.7K | 70,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-07 | 2018-06-12 | 14,800 | $4.32 | $63.9K | 64,766 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-06 | 2018-06-12 | 9,100 | $4.35 | $39.6K | 49,966 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-05 | 2018-06-12 | 8,400 | $4.28 | $36.0K | 40,866 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-04 | 2018-06-12 | 3,800 | $4.19 | $15.9K | 32,466 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2018-06-01 | 2018-06-12 | 8,666 | $4.15 | $36.0K | 28,666 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2018-04-25 | 2018-04-25 | 1,000 | $3.80 | $3.8K | 52,500 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2017-10-17 | 2017-10-18 | 1,000 | $5.01 | $5.0K | 51,500 | SEC↗ |
| Herskowitz Neil | Director | P Buy | 2017-10-09 | 2017-10-10 | 500 | $5.24 | $2.6K | 50,500 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2017-10-09 | 2017-10-10 | 1,350 | $5.40 | $7.3K | 20,000 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2017-10-06 | 2017-10-10 | 2,900 | $5.63 | $16.3K | 18,650 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2017-10-05 | 2017-10-10 | 3,550 | $5.60 | $19.9K | 15,750 | SEC↗ |
| ROSENWALD LINDSAY A MD | Director | P Buy | 2017-10-04 | 2017-10-10 | 2,200 | $5.60 | $12.3K | 12,200 | SEC↗ |
| Lu Lucy | President, CEO | A Award | 2017-09-28 | 2017-10-02 | 4,000 | $5.20 | $20.8K | 552,333 | SEC↗ |